NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. ("Verizon") ((NYSE, NASDAQ:VZ) today announced the expiration and final results, as of 5:00 p.m. (New York City time) on June 16, 2026 (the "Expiration Date"), which was also the Any and All Notes Extended Early Participation Date (as defined in Verizon's press releases relating to the Tender Offers and Consent Solicitations dated June 2, 2026 (collectively, the "June 2026 Press Release") of its previously announced 11 separate offers, on behalf of certain of its wholly-owned subsidiaries, to purchase for cash any and all of the debt securities listed in Table 1 below (the "Any and All Notes" and such offers, the "Any
Live Feed
Delayed 3mPress · Insider · SEC · FDA · Financials
Signed out · 3-min delay · Sign up for real-time
- Verizon announces expiration and final results of its tender offers and consent solicitations for 20 series of Verizon and certain of its subsidiaries' notes
- Verizon announces expiration and final results of its private exchange offers and consent solicitations for 11 series of notes
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Verizon Communications Inc. ("Verizon") ((NYSE, NASDAQ:VZ) today announced the expiration and final results, as of 5:00 p.m. (New York City time) on June 16, 2026 (the "Expiration Date"), which was also the Extended Early Participation Date (as defined in Verizon's press release relating to the Exchange Offers and Consent Solicitations dated June 2, 2026 (the "Early Results Press Release"), of its previously announced (i) offers to exchange (the "Exchange Offers"), on behalf of certain of its wholly-owned subsidiaries, any and all of the outstanding series of debt securities listed below (the "Old Notes") for specified series of newly issued note
- Chief Medical Officer Yu Jeffrey bought $100,000 worth of shares (172,414 units at $0.58), increasing direct ownership by 2% to 8,621,680 units (SEC Form 4)
4 - OneMedNet Corp (0001849380) (Issuer)
- Dyne Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
8-K - Dyne Therapeutics, Inc. (0001818794) (Filer)
- Diana Shipping Inc. Raises Offer to Acquire Genco Shipping & Trading to $27.34 Per Share Comprised of $24.80 in Cash and One Diana Share
Diana Shares Valued at $2.54 Per Share Based on Diana's Volume-Weighted Average Price for the 30 Days Ended on June 16, 2026 Revised Offer Reflects a 53% Premium to Genco's Undisturbed Share Price and a 6% Premium to NAV at Cyclically High Drybulk Asset Values at or Near 15-Year Highs Provides Genco Shareholders Immediate Cash Certainty Plus Opportunity for Equity Participation in the Combined Company Diana Requests That Genco Delay the Annual Meeting Currently Scheduled for June 18 to Allow the Board and Shareholders Time to Properly Evaluate the Increased Offer CEO Semiramis Paliou and Other Diana Executives Intend to Maintain Their Existing Ownership Percentages in Diana Through Open
- Jabil Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - JABIL INC (0000898293) (Filer)
- High Credit Inquiry Velocity Emerges as Top Fraud Risk Indicator in Rental Applications
NEW ORLEANS, June 17, 2026 (GLOBE NEWSWIRE) -- Rental applicants with unusually high numbers of recent credit inquiries pose the greatest fraud risk for property managers, according to TransUnion (NYSE:TRU) research released today at Apartmentalize 2026. Applicants with 15 or more credit inquiries in the seven days prior to applying for a lease showed the highest rate of charge-offs within one year, at 32%, compared with nearly 9% for the overall sample. The research identified the top 15 fraud indicators based on their ability to help predict a negative outcome within 12 months after a renter applied for a lease. Another leading indicator was having eight or more credit inquiries within
- Director Foletta Mark G sold $114,362 worth of shares (3,681 units at $31.07) as part of a pre-agreed trading plan (SEC Form 4)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
- Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced that its wholly owned subsidiary, MitoCareX Bio Ltd. ("MitoCareX"), today reported that it has completed a broad structural analysis of human SLC (Solute Carrier) transport proteins as part of its ongoing efforts to expand and refine its small-molecule discovery capabilities. This work builds on MITOLINE®, MitoCareX's proprietary sequence analysis and alignment algorithm, which to date has been used to prepare mitochondrial SLC25 carri
- N-able Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - N-able, Inc. (0001834488) (Filer)
- Atlas Lithium CEO to Deliver Keynote Address at the 3rd Brazil Lithium & Critical Minerals Summit
Boca Raton, Florida--(Newsfile Corp. - June 17, 2026) - Atlas Lithium Corp. (NASDAQ:ATLX) ("Atlas Lithium" or the "Company") today announced that Chairman and CEO Marc Fogassa will deliver the Strategic Keynote Presentation opening the first session, "Lithium in Brazil: Building a Competitive Industry," at the 3rd Brazil Lithium & Critical Minerals Summit 2026, to be held June 17-18 in Belo Horizonte, Minas Gerais, Brazil. The summit is recognized as the premier business and investment platform for Brazil's growing critical minerals sector.Fogassa's keynote will highlight how Brazil is building a globally competitive critical minerals supply chain, supported by a stable jurisdiction, establi
- Amendment: Soluna Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits
8-K/A - Soluna Holdings, Inc (0000064463) (Filer)
- Graham Corporation filed SEC Form 8-K: Regulation FD Disclosure
8-K - GRAHAM CORP (0000716314) (Filer)
- SEC Form 6-K filed by Wellchange Holdings Company Limited
6-K - Wellchange Holdings Co Ltd (0001990251) (Filer)
- Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in First-Line Metastatic Pancreatic Cancer
90% of patients in the study presented with metastatic (Stage IV) disease at diagnosis 6-month overall survival rate was 86%; follow-up continues and survival data continue to mature Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced positive updated safety and efficacy results from the RAMP 205 Phase 1b/2a Recommended Phase 2 Dose (RP2D) cohort of 29 patients evaluating avutometinib plus defactinib in combination with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic ductal adenocarcinoma (PDAC). KRAS is mutated in more than 90% of pancreatic cancers, mak
- Jabil Posts Third Quarter Results
Raises Fiscal 2026 Outlook Today, Jabil Inc. (NYSE:JBL), reported preliminary, unaudited financial results for its third quarter of fiscal year 2026. Third Quarter of Fiscal Year 2026 Highlights: Net revenue: $8.8 billion U.S. GAAP operating income: $445 million U.S. GAAP diluted earnings per share: $2.59 Core operating income (Non-GAAP): $504 million Core diluted earnings per share (Non-GAAP): $3.16 "Jabil delivered a very strong third quarter, with results ahead of our expectations across revenue, core operating margin, core EPS, and free cash flow," said CEO Mike Dastoor. "AI infrastructure demand remains extremely strong, and our full-year AI-related revenue outloo
- JPAR Founder JP Piccinini Aligns with Real to Help Agents and Brokerage Leaders Scale
Entrepreneur brings two decades of experience building high-growth brokerages and agent-centric businesses The Real Brokerage Inc. (NASDAQ:REAX), a real estate technology platform focused on innovation and agent culture, today announced that entrepreneur and JPAR Real Estate founder JP Piccinini will be working with Real as a Growth Leader. In this role, he will work closely with Chief Growth Officer Jason Cassity to support agents, teams and brokerage leaders across the Real network. Over the course of his career, Piccinini has served as an agent, brokerage owner, franchisee and franchisor, giving him a broad perspective on the real estate industry at every stage of business developmen
- The Hillman Group and Hillwood Celebrate Groundbreaking of New Multipurpose Facility
FOREST PARK, Ohio, June 17, 2026 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (NASDAQ:HLMN) (the "Company", "Hillman Group", or "Hillman"), a leading provider of hardware products and merchandising solutions, and Hillwood Investment Properties ("Hillwood"), held a groundbreaking ceremony for a new multipurpose facility at the former Forest Fair Mall site in Forest Park, Ohio. The project marks a major milestone in the transformation of the long-vacant property into a modern multipurpose facility and brought together leaders from local government, economic development organizations, and redevelopment partners to commemorate the occasion. Hillman will lease and fully occupy the space as its